Global Blood Therapeutics Inc


Global Blood Therapeutics Up On Expanded Use Plans For Sickle Cell Treatment

Shares in Global Blood Therapeutics (GBT) rose 5% in Monday’s extended trading after the company announced plans to expand the potential use of …

3 Monster Growth Stocks That Are Ready for the Next Leg Higher

At the end of the day, investors want to see returns. To accomplish this goal, seasoned Wall Street observers often turn to one …

Roth Capital’s Focus Pick: Global Blood Therapeutics Inc (GBT)

Global Blood Therapeutics Inc (NASDAQ:GBT) shares rose about 9% today after the biopharmaceutical company initiated a Phase 1 trial evaluating GBT440 in healthy volunteers under hypoxic …

Roth Capital Maintains Positive Stance on Global Blood Therapeutics Inc (GBT) Following Updated Clinical Results for GBT440

Roth Capital analyst Mark Breidenbach is out today with a favorable report on shares of Global Blood Therapeutics Inc (NASDAQ:GBT), after the company provided updated …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts